Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.83%
+4.73%
-1.56%
-1.11%
ENTA
Enanta Pharmaceuticals In
$11.46
Login to see Enanta Pharmaceuticals In (ENTA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Risk Analysis
Earnings are forecast to decrease
Chart
$8.66 (+32.33%)
$7.09 (+61.64%)
$5.75 (+99.30%)
$13 (-11.85%)
ENTA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
High volatilty
ENTA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
ENTA Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ENTA Street view is bullish but have mixed views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ENTA current stock price?
What are ENTA stock strengths?
What risks are associated with ENTA stock?
When is ENTA next earnings report?
What is ENTA market cap and volume?
What is ENTA's current Stock IQ?
Should I buy ENTA stock right now?
Is ENTA a Strong Buy right now?
What does a 'Strong Buy' rating mean for ENTA?
What does a 'Strong Sell' rating mean for ENTA?
What factors influence ENTA's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.83%
+4.73%
-1.56%
-1.11%
ENTA
Enanta Pharmaceuticals In
Current Price
$11.46
Stock Insights
Strengths
Upgraded on attractively valued
Risk Analysis
Earnings are forecast to decrease
Login to unlock Enanta Pharmaceuticals In (ENTA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$8.66 (+32.33%)
$7.09 (+61.64%)
$5.75 (+99.30%)
$13 (-11.85%)
ENTA Analysts Opinion
ENTA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
ENTA Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ENTA Street view is bullish but have mixed views on the near-term outlook
ENTA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
High volatilty
Average key support and resistance price levels.
Login to displayENTA Latest Analysis
WestPark Capital Maintains Enanta Pharmaceuticals (ENTA) Buy Recommendation. Fintel reports that on September 30 2025 WestPark Capital maintained coverage of Enanta Pharmaceuticals (NasdaqGS:ENTA) with a Buy recommendation. Analyst Price Forecast Suggests 24.95% Upside
Tue Sep 30, 2025
Enantas Oral Antiviral Shows Key Benefit For High-Risk Adults With RSV In Phase 2b Trial. Stock Up . (RTTNews) - Enanta Pharmaceuticals Inc. (ENTA) has reported topline data from its RSVHR study of Zelicapavir demonstrating a clinically meaningful benefit in high-risk adults infected with RSV.
Mon Sep 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ENTA Stock trends
ENTA Stock performance
ENTA Stock analysis
ENTA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings
Leaders